

GSK
"A global biopharma company uniting science, technology and talent to get ahead of disease"
About GSK
GSK is a focused biopharmaceutical company that discovers, develops and delivers medicines and vaccines to prevent and treat disease. Operating across 70 markets, the company concentrates on four therapeutic areas: respiratory, immunology and inflammation, oncology, HIV, and infectious diseases. With deep expertise in the immune system, GSK creates specialty medicines, vaccines and general medicines for patients globally. The company tackles healthcare challenges from cancer to HIV and infectious disease threats. GSK combines research and development with responsible business practices to make treatments accessible worldwide. With 66,800 people collaborating globally, GSK aims to positively impact 2.5 billion people by decade's end.


66800
Team Members
1715
Founded
Public
Funding
Hybrid
Work Environment
A healthier world where disease no longer limits human potential, where cancer is curable rather than deadly, where the HIV epidemic has ended, and where 2.5 billion people experience measurably improved health and wellbeing.
GSK unites science, technology and talent to get ahead of disease together.